ArticleJournal of education and health promotion2025
Challenges and future directions of gastric cancer prevention in Iran: Perspectives of the key stakeholders.
Article in Journal of education and health promotion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer (GC) is a critical public health concern that demands urgent attention. It is one of the most prevalent cancers in Iran, and it also has the highest mortality rate among all other cancers. Despite being recognized as one of the most preventable types of cancer worldwide, the healthcare system in Iran faces considerable challenges in preventing GC to curb its incidence effectively. This qualitative study explores the perspectives of public health and clinical experts regarding these complexities and explains how more effective preventive measures could be developed. MATERIALS AND
methodsAn exploratory qualitative study was conducted in Iran from December 2023 to June 2024. The data collection involved semistructured, in-depth, face-to-face interviews with 31 experts in various fields related to GC, including education, research, prevention, diagnosis, treatment, and management. These experts are affiliated with organizations such as the Ministry of Health and Medical Education, medical universities, hospitals, health centers, cancer research centers, education and research centers, the Iranian Cancer Association, and The Academy of Medical Sciences of the Islamic Republic of Iran, Tehran. Transcripts of the interviews formed the content of the data for analysis. Conventional content analysis of the data was conducted using MAXQDA 20.
resultsThe experts' perspectives were categorized into two main sections: (1) the challenges of GC prevention in Iran, along with the barriers hindering the implementation of prevention, and (2) strategies for enhancing the prevention system. These strategies include fostering a healthier culture, increasing health status and value, empowering individuals regarding cancer prevention, and developing health-supportive environments.
conclusionGiven the prevalence and mortality rate of GC in Iran, its prevention requires greater attention. The findings of our study emphasize the importance of GC prevention in Iran, which requires more attention and a shift from a medical approach to a social one. In this regard, the most important effective interventions are building health-related public laws aimed at creating a healthy social and biological environment and health promotional products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.